Literature DB >> 25972281

Misled by the Morning "Fasting" Plasma Glucose.

Allen B King1.   

Abstract

Because of its ease and simplicity of its measurement, the morning fasting plasma glucose (FPG), has been as used a surrogate marker for the entire basal day when titrating once-nightly basal insulin. Common in obese insulin-treated patients with type 2 diabetes, late and large evening meals elevate the FPG. This has led to dosing of basal insulin well beyond the basal requirements and contributes to hypoglycemia and weight gain seen with this therapy. It is recommended that during basal insulin titration, the evening meal be limited and hypoglycemia be monitored early in the morning, that bewitching time when the "peakless" basal insulin's action is peaking and the predawn phenomenon insulin sensitivity is higher.
© 2015 Diabetes Technology Society.

Entities:  

Keywords:  basal insulin; fasting morning glucose; hypoglycemia; insulin; weight gain

Mesh:

Substances:

Year:  2015        PMID: 25972281      PMCID: PMC4667307          DOI: 10.1177/1932296815586425

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  25 in total

1.  Effects of a large supper on glucose levels the following morning in patients with type 2 diabetes.

Authors:  C Arauz-Pacheco; G Clements; S Cercone; L Brinkley; P Raskin
Journal:  J Diabetes Complications       Date:  1998 Mar-Apr       Impact factor: 2.852

2.  When is enough, enough? The correlation between once-daily basal insulin doses to the fasting plasma glucose in type 2 diabetes.

Authors:  Allen B King
Journal:  Endocr Pract       Date:  2013 Jul-Aug       Impact factor: 3.443

3.  Effect of temporal distribution of calories on diurnal patterns of glucose levels and insulin secretion in NIDDM.

Authors:  C A Beebe; E Van Cauter; E T Shapiro; H Tillil; R Lyons; A H Rubenstein; K S Polonsky
Journal:  Diabetes Care       Date:  1990-07       Impact factor: 19.112

Review 4.  Variability of insulin absorption and insulin action.

Authors:  Lutz Heinemann
Journal:  Diabetes Technol Ther       Date:  2002       Impact factor: 6.118

5.  Adherence patterns in patients with type 2 diabetes on basal insulin analogues: missed, mistimed and reduced doses.

Authors:  Meryl Brod; Azhar Rana; Anthony H Barnett
Journal:  Curr Med Res Opin       Date:  2012-11-14       Impact factor: 2.580

6.  Binge eating disorder and night eating syndrome in adults with type 2 diabetes.

Authors:  Kelly C Allison; Scott J Crow; Rebecca R Reeves; Delia Smith West; John P Foreyt; Vicki G Dilillo; Thomas A Wadden; Robert W Jeffery; Brent Van Dorsten; Albert J Stunkard
Journal:  Obesity (Silver Spring)       Date:  2007-05       Impact factor: 5.002

7.  The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

Authors:  Matthew C Riddle; Julio Rosenstock; John Gerich
Journal:  Diabetes Care       Date:  2003-11       Impact factor: 19.112

8.  Slow-wave sleep and the risk of type 2 diabetes in humans.

Authors:  Esra Tasali; Rachel Leproult; David A Ehrmann; Eve Van Cauter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-02       Impact factor: 11.205

Review 9.  Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?

Authors:  Michael H Shanik; Yuping Xu; Jan Skrha; Rachel Dankner; Yehiel Zick; Jesse Roth
Journal:  Diabetes Care       Date:  2008-02       Impact factor: 19.112

10.  Chronotype is independently associated with glycemic control in type 2 diabetes.

Authors:  Sirimon Reutrakul; Megan M Hood; Stephanie J Crowley; Mary K Morgan; Marsha Teodori; Kristen L Knutson; Eve Van Cauter
Journal:  Diabetes Care       Date:  2013-05-01       Impact factor: 19.112

View more
  3 in total

1.  Free-Living Humans Cross Cardiovascular Disease Risk Categories Due to Daily Rhythms in Cholesterol and Triglycerides.

Authors:  Azure D Grant; Gary I Wolf
Journal:  J Circadian Rhythms       Date:  2019-04-24

Review 2.  Efficacies of Stem Cell Therapies for Functional Improvement of the β Cell in Patients with Diabetes: A Systematic Review of Controlled Clinical Trials.

Authors:  Gyudeok Hwang; Hyunsuk Jeong; Hae Kyung Yang; Hun-Sung Kim; Hanter Hong; Na Jin Kim; Il-Hoan Oh; Hyeon Woo Yim
Journal:  Int J Stem Cells       Date:  2019-07-31       Impact factor: 2.500

Review 3.  Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist.

Authors:  Dhiren Patel; Curtis Triplitt; Jennifer Trujillo
Journal:  Adv Ther       Date:  2019-03-21       Impact factor: 3.845

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.